178 related articles for article (PubMed ID: 30515664)
41. Haemophilia care in Europe: the ESCHQoL study.
Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
[TBL] [Abstract][Full Text] [Related]
42. The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation.
Hay CRM; Xiang H; Scott M; Collins PW; Liesner R; Dolan G; Hollingsworth R
Haemophilia; 2017 Sep; 23(5):728-735. PubMed ID: 28806858
[TBL] [Abstract][Full Text] [Related]
43. Do patients with haemophilia and von Willebrand disease with arterial hypertension have bleeding complications: a German single centre cohort.
Alesci RS; Krekeler S; Seifried E; Miesbach W
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):320-3. PubMed ID: 22473050
[TBL] [Abstract][Full Text] [Related]
44. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.
Byams VR; Kouides PA; Kulkarni R; Baker JR; Brown DL; Gill JC; Grant AM; James AH; Konkle BA; Maahs J; Dumas MM; McAlister S; Nance D; Nugent D; Philipp CS; Soucie JM; Stang E;
Haemophilia; 2011 Jul; 17 Suppl 1(0 1):6-13. PubMed ID: 21692922
[TBL] [Abstract][Full Text] [Related]
45. Congenital bleeding disorders in Karachi, Pakistan.
Borhany M; Shamsi T; Naz A; Khan A; Parveen K; Ansari S; Farzana T
Clin Appl Thromb Hemost; 2011; 17(6):E131-7. PubMed ID: 21247962
[TBL] [Abstract][Full Text] [Related]
46. A three-year study of adolescent boys suffering from haemophilia and allied disorders.
Rainsford SG; Hall A
Br J Haematol; 1973 May; 24(5):539-51. PubMed ID: 4541300
[No Abstract] [Full Text] [Related]
47. Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project.
Fischer K; Lassila R; Peyvandi F; Calizzani G; Gatt A; Lambert T; Windyga J; Iorio A; Gilman E; Makris M;
Thromb Haemost; 2015 May; 113(5):968-75. PubMed ID: 25567324
[TBL] [Abstract][Full Text] [Related]
48. The World Federation of Hemophilia Annual Global Survey 1999-2018.
Stonebraker JS; Bolton-Maggs PHB; Brooker M; Evatt B; Iorio A; Makris M; O'Mahony B; Skinner MW; Coffin D; Pierce GF; Tootoonchian E
Haemophilia; 2020 Jul; 26(4):591-600. PubMed ID: 32497379
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of hepatitis C virus infection among patients with inherited bleeding disorders in Newfoundland.
Ali SK; Ozere R; Kutty KM; Richards H; Ratnam S; St Croix E; Bishai FR
Can Commun Dis Rep; 1992 Jun; 18(12):91-2, 95. PubMed ID: 1299427
[No Abstract] [Full Text] [Related]
50. Inherited bleeding syndromes in Jordan.
Alsabti EA; Hammadi M
Acta Haematol; 1979; 61(1):47-51. PubMed ID: 105540
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis and treatment challenges in lower resource countries: State-of-the-art.
Mahlangu J; Diop S; Lavin M
Haemophilia; 2024 Apr; 30 Suppl 3():78-85. PubMed ID: 38462793
[TBL] [Abstract][Full Text] [Related]
52. Haemophilia and allied disorders in the Sudan.
Omer A; Ziada M
Br J Haematol; 1973 Jul; 25(1):69-75. PubMed ID: 4545825
[No Abstract] [Full Text] [Related]
53. Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry.
Fischer K; Ljung R; Platokouki H; Liesner R; Claeyssens S; Smink E; van den Berg HM
Haemophilia; 2014 Jul; 20(4):e280-6. PubMed ID: 24784937
[TBL] [Abstract][Full Text] [Related]
54. Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements.
Skinner MW
Br J Haematol; 2011 Sep; 154(6):704-14. PubMed ID: 21707577
[TBL] [Abstract][Full Text] [Related]
55. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).
Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B;
Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606
[TBL] [Abstract][Full Text] [Related]
56. Haemophilia patients aged 0-18 years in the Western Cape.
Hazewinkel MH; Hoogerwerf JJ; Hesseling PB; Hartley P; MacLean PE; Peters M; Wessels G
S Afr Med J; 2003 Oct; 93(10):793-6. PubMed ID: 14652975
[TBL] [Abstract][Full Text] [Related]
57. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Asatiani E; Kessler CM;
Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
[TBL] [Abstract][Full Text] [Related]
58. [Rare bleeding disorders and invasive procedures].
Bonhomme F; Schved JF; Giansily-Blaizot M; Samama CM; de Moerloose P
Ann Fr Anesth Reanim; 2013 Mar; 32(3):198-205. PubMed ID: 23422342
[TBL] [Abstract][Full Text] [Related]
59. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
Osooli M; Steen Carlsson K; Astermark J; Berntorp E
Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
[TBL] [Abstract][Full Text] [Related]
60. Spectrum of inherited bleeding disorders from Western India.
Manisha M; Ghosh K; Shetty S; Nair S; Khare A; Kulkarni B; Pathare AV; Baindur S; Mohanty D
Haematologia (Budap); 2002; 32(1):39-47. PubMed ID: 12243554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]